EBA
IART icon

Eagle Bay Advisors’s Integra LifeSciences IART Stock Holding History

Eagle Bay Advisors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35
Closed -$1.24K – 996
2024
Q1 		$1.24K Buy
+35
New +$1.4K ﹤0.01% 916

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Eagle Bay Advisors's IART Position: Q2 2024 in Review

Eagle Bay Advisors sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 35 shares — an estimated $1.24K sold.

Eagle Bay Advisors first reported a position in IART in Q1 2024 and held it in 1 quarter. The position peaked at $1.24K in Q1 2024. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Eagle Bay Advisors reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Eagle Bay Advisors sold 35 Integra LifeSciences shares in Q2 2024, an estimated $1.24K.
  • Eagle Bay Advisors first reported a position in Integra LifeSciences in Q1 2024 and held it in 1 quarter.
  • Eagle Bay Advisors's Integra LifeSciences position peaked at $1.24K in Q1 2024.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Eagle Bay Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.